Evidence map›Paper›PMID 40236562›Full record

ArticleACS medicinal chemistry letters2025

Design, Synthesis, Evaluation, and Molecular Dynamics Simulation of SARS-CoV-2 M

Qinghua Yang, Keli Zong, Xu Zhao, Fenghua Zhang, Fei Li, Xingzhou Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS medicinal chemistry letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qinghua YangCollege of Petrochemical Engineering, Liaoning Petrochemical University, Liaoning 113001, China.
Keli ZongCollege of Chemistry and Life Science, Beijing University of Technology, Beijing 100124, P. R. China.
Xu ZhaoDepartment of Hepatology, Fifth Medical Center of Chinese PLA General Hospital, 100 West Fourth Ring Road, Beijing100071, China.
Fenghua ZhangCollege of Petrochemical Engineering, Liaoning Petrochemical University, Liaoning 113001, China.
Fei LiCollege of Petrochemical Engineering, Liaoning Petrochemical University, Liaoning 113001, China.
Xingzhou LiBeijing Institute of Pharmacology and Toxicology, 27 Taiping Road, Beijing 100850, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19, caused by SARS-CoV-2, is a highly contagious disease with significant transmissibility and pathogenicity. The main protease of SARS-CoV-2 (M

Identifiers

PMID40236562
PMCPMC11995235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.